# FDA Inspection 1120314 - Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit - January 16, 2020

Source: https://www.keypedia.com/records/fda_inspections/arab-pharmaceutical-industry-consultingpharmaceutical-research-unit/c119b2e7-3c85-4701-8185-e68a83dc9038
Source feed: FDA_Inspections

> FDA Inspection 1120314 for Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit on January 16, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120314
- Company Name: Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
- Inspection Date: 2020-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1122366 - 2020-03-12](https://www.keypedia.com/records/fda_inspections/arab-pharmaceutical-industry-consultingpharmaceutical-research-unit/3a8a9d1e-f9da-48d3-818e-feba8adcef2d)

Company: https://www.keypedia.com/companies/arab-pharmaceutical-industry-consultingpharmaceutical-research-unit/a31217df-a951-4672-a972-d0533250c011

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c